首页> 中文期刊> 《世界重症医学杂志》 >Plasma-Lyte 148:A clinical review

Plasma-Lyte 148:A clinical review

         

摘要

AIM To outline the physiochemical properties and specific clinical uses of Plasma-Lyte 148 as choice of solution for fluid intervention in critical illness,surgery and perioperative medicine.METHODS We performed an electronic literature search from Medline and PubMed(via Ovid),anesthesia and pharmacology textbooks,and online sources including studies that compared Plasma-Lyte 148 to other crystalloid solutions.The following keywords were used:“surgery”,“anaesthesia”,“anesthesia”,“anesthesiology”,“anaesthesiology”,“fluids”,“fluid therapy”,“crystalloid”,“saline”,“plasma-Lyte”,“plasmalyte”,“hartmann’s”,“ringers”“acetate”,“gluconate”,“malate”,“lactate”.All relevant articles were accessed in full.We summarized the data and reported the data in tables and text.RESULTS We retrieved 104 articles relevant to the choice of Plasma-Lyte 148 for fluid intervention in critical illness,surgery and perioperative medicine.We analyzed thedata and reported the results in tables and text.CONCLUSION Plasma-Lyte 148 is an isotonic,buffered intravenous crystalloid solution with a physiochemical composition that closely reflects human plasma.Emerging data supports the use of buffered crystalloid solutions in preference to saline in improving physicochemical outcomes.Further large randomized controlled trials assessing the comparative effectiveness of Plasma-Lyte 148 and other crystalloid solutions in measuring clinically important outcomes such as morbidity and mortality are needed.

著录项

相似文献

  • 中文文献
  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号